Notre Dame researchers discover ‘oxadiazoles’, a new class of antibiotics for MRSA treatment
A new class of antibiotics have been discovered that show promise in treating difficult to treat infections caused by Methicillin Resistant Staphylococcus aureus (MRSA) and other threats to public health. MRSAImage/CDC Researchers More...
Becton Dickinson receives FDA clearance to market the BD MAX™ StaphSR Assay
Press Release BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced yesterday it has received FDA clearance to market the BD MAX™ StaphSR More...
MRSA infections down in all categories, hospital acquired down more than 50% according to study
Infections caused by Methicillin-resistant Staphylococcus aureus, or MRSA, has decreased in all settings, according to new data published in The Journal of the American Medical Association (JAMA), Internal Medicine More...
Buccaneers, Carl Nicks and Lawrence Tynes sidelined with MRSA infections, One Buc Place sanitized
Two Tampa Bay Buccaneers have been diagnosed with Methicillin-resistant Staphylococcus aureus, better known as MRSA infections prompting the signing of a new kicker and a thorough sanitizing of One Buc Place. Credits: More...
Antimicrobial soap and ointments best to reduce MRSA infections in ICU patients: Study
Using germ-killing soap and ointment on all intensive-care unit (ICU) patients can reduce bloodstream infections by up to 44 percent and significantly reduce the presence of methicillin-resistant Staphylococcus More...
Antibiotic candidate, dalbavancin, designated as a Qualified Infectious Disease Product by the FDA
The intravenous antibiotic product candidate, dalbavancin, has been designated as a Qualified Infectious Disease Product (QIDP) by the Food and Drug Administration (FDA), making it eligible for fast-track status, More...
